Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, October 1999, p. 2366-2371, Vol. 43, No. 10
Unité des Agents Antibactériens,
Received 7 April 1999/Returned for modification 30 June
1999/Accepted 27 July 1999
The aac(6')-Iz gene of Stenotrophomonas
maltophilia BM2690 encoding an aminoglycoside
6'-N-acetyltransferase was characterized. The gene was
identified as a coding sequence of 462 bp corresponding to a protein
with a calculated mass of 16,506 Da, a value in good agreement with
that of ca. 16,000 found by in vitro coupled transcription-translation. Analysis of the deduced amino acid sequence indicated that the protein
was a member of the major subfamily of aminoglycoside 6'-N-acetyltransferases. The enzyme conferred resistance to
amikacin but not to gentamicin, indicating that it was an AAC(6') of
type I. The open reading frame upstream from the aac(6')-Iz
gene was homologous to the fprA gene of Myxococcus
xanthus (61% identity), which encodes a putative pyridoxine
(pyridoxamine) 5'-phosphate oxidase. Pulsed-field gel electrophoresis
of total DNA from BM2690 and S. maltophilia ATTC 13637 digested with XbaI, DraI, and SpeI followed by hybridization with rRNA and aac(6')-Iz-specific
probes indicated that the gene was located in the chromosome. The
aac(6')-Iz gene was detected by DNA-DNA hybridization in
all 80 strains of S. maltophilia tested. The MICs of
gentamicin against these strains of S. maltophilia were
lower than those of amikacin, netilmicin, and tobramycin, indicating
that production of AAC(6')-Iz contributes to aminoglycoside resistance
in S. maltophilia.
0066-4804/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Characterization of the Chromosomal
aac(6')-Iz Gene of Stenotrophomonas
maltophilia
*
Corresponding author. Mailing address: Unité des
Agents Antibactériens, 28 rue du Docteur Roux, Institut Pasteur,
75724 Paris Cedex15, France. Phone: (33) (1) 45 68 83 21. Fax: (33) (1)
45 68 83 19. E-mail: tlambert{at}pasteur.fr.
Antimicrobial Agents and Chemotherapy, October 1999, p. 2366-2371, Vol. 43, No. 10
0066-4804/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
| Clin. Vaccine Immunol. | Clin. Microbiol. Rev. |
|---|---|
| J. Clin. Microbiol. | ALL ASM JOURNALS |